医疗产业ETF(159877.SZ)涨1.99%，乐普医疗涨6.58%

Group 1 - The core viewpoint of the article highlights the positive impact of new policies on the medical industry, particularly in pathology services and medical equipment, which are expected to drive growth in the sector [1] - The medical industry ETF (159877.SZ) has seen a rise of 1.99%, with specific stocks like Lepu Medical increasing by 6.58%, indicating strong market interest [1] - The implementation of refined pricing policies for pathology services is set to standardize and digitize the sector, enhancing the value of digital technologies such as digital slicing and remote diagnosis [1] Group 2 - The government is expected to continue promoting medical equipment updates through 2026, focusing on optimizing application conditions and supporting small and medium-sized enterprises, which will likely boost the bidding environment for medical devices [1] - As company inventory levels clear, a turning point in industry performance is anticipated, with particularly strong demand for high-end medical equipment [1] - The dual policy benefits are expected to significantly benefit the medical industry ETF, especially in the areas of pathology diagnosis and high-end medical equipment [1]